Jeff J. Musgnung, MS
- 2Articles
- 7.2KReads1
- 2010–2011Active
- 7Collaborators
- 61Citations2
About
Jeff J. Musgnung, MS, has contributed to research on major depressive disorder (MDD), focusing on treatment outcomes with antidepressant medications. His publications include studies on the efficacy and safety of venlafaxine extended release, selective serotonin reuptake inhibitors, and desvenlafaxine in diverse patient populations, including perimenopausal and postmenopausal women. His work appeared in Psychiatrist.com between 2010 and 2011.
Publications
Remission With Venlafaxine Extended Release or Selective Serotonin Reuptake Inhibitors in Depressed Patients: A Randomized, Open-Label Study
February 24, 2011
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
